Translocation (4;19)(q35;q13.1)-associated primitive round cell sarcoma: Report of a case and review of the literature

Pediatric and Developmental Pathology

Volumn 11, Issue 3, 2008, Pages 239-244

  Rakheja, Dinesh ^a,b   Goldman, Stanton ^b   Wilson, Kathleen S ^a   Lenarsky, Carl ^b   Weinthal, Joel ^b   Schuttz, Roger A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TEXAS ONCOLOGY   (United States)

Author keywords

Cytogenetics; Ewing sarcoma; Primitive round cell sarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GADOLINIUM; VINCRISTINE;

ARTICLE; BONE BIOPSY; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME 19Q; CHROMOSOME 4Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 4; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; ECHOGRAPHY; EWING SARCOMA; FOLLOW UP; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; LUNG NODULE; MALE; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIMITIVE ROUND CELL SARCOMA; PRIORITY JOURNAL; SARCOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 4; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; SARCOMA, SMALL CELL; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 48849104267     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/07-06-0296.1     Document Type: Article

References (23)

1. Barch MJ, Knutsen T, Spurbeck JL, eds. The AGT Cytogenetics Laboratory Manual, 3rd ed. New York: Raven Press, 1997.
2. Mitelman F, ed. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger, 1995.
3. Richkind KE, Romansky SG, Finklestein JZ. t(4;19)(q35;q13.1): a recurrent change in primitive mesenchymal tumors? Cancer Genet Cytogenet 1996;87:71-74.
4. Kawamura-Saito M, Yamazaki Y, Kaneko K, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 2006;15:2125-2137.
5. Roberts P, Browne CF, Lewis IJ, et al. 12q13 abnormality in rhabdomyosarcoma. A nonrandom occurrence? Cancer Genet Cytogenet 1992;60:135-140.
6. Urumov IJ, Manolova Y. Cytogenetic analysis of an embryonal rhabdomyosarcoma cell line. Cancer Genet Cytogenet 1992;61:214-215.
7. Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 2001;20:5747-5754.
8. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162-165.
9. Zucman J, Melot T, Desmaze C, et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 1993;12:4481-4487.
10. Jeon IS, Davis JN, Braun BS, et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995;10:1229-1234.
11. Kaneko Y, Yoshida K, Handa M, et al. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 1996;15:115-121.
12. Peter M, Couturier J, Pacquement H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 1997;14:1159-1164.
13. Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res 2003;63:4568-4576.
14. Janknecht R. EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene 2005;363:1-14.
15. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701.
16. Lee CJ, Chan WI, Cheung M, et al. CIC, a member of a novel subfamily of the HMG-box superfamily, is transiently expressed in developing granule neurons. Brain Res Mol Brain Res 2002;106:151-156.
17. Lee CJ, Chan WI, Scotting PJ. CIC, a gene involved in cerebellar development and ErbB signaling, is significantly expressed in medulloblastomas. J Neurooncol 2005;73:101-108.
18. Tseng AS, Tapon N, Kanda H, et al. Capicua regulates cell proliferation downstream of the receptor tyrosine kinase/ras signaling pathway. Curr Biol 2007;17:728-733.
19. van Deutekom JC, Wijmenga C, van Tienhoven EA, et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993;2:2037-2042.
20. Gabriels J, Beckers MC, Ding H, et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 1999;236:25-32.
21. Kowaljow V, Marcowycz A, Ansseau E, et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord 2007;17:611-623.
22. Lucas DR, Bentley G, Dan ME, Tabaczka P, Poulik JM, Mott MP. Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study. Am J Clin Pathol 2001;115:11-17.
23. Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000;24:1657-1662.